Revance Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.5M | 172k | 8.79 |
| 2023-09-30 | $1.6M | 141k | 11.47 |
| 2023-06-30 | $3.6M | 142k | 25.31 |
| 2023-03-31 | $4.5M | 139k | 32.21 |
| 2022-12-31 | $2.4M | 130k | 18.46 |
| 2022-09-30 | $2.6M | 97k | 26.99 |
| 2022-06-30 | $1.3M | 91k | 13.81 |
| 2022-03-31 | $1.8M | 91k | 19.50 |
| 2021-12-31 | $1.4M | 85k | 16.25 |
| 2021-09-30 | $2.4M | 86k | 27.90 |
| 2021-06-30 | $2.4M | 82k | 29.69 |
| 2021-03-31 | $4.5M | 86k | 52.63 |
| 2020-12-31 | $4.0M | 108k | 37.04 |
| 2020-09-30 | $1.4M | 56k | 25.14 |
| 2020-06-30 | $1.2M | 50k | 24.43 |
| 2020-03-31 | $878k | 60k | 14.75 |
| 2019-12-31 | $567k | 35k | 16.19 |
| 2019-09-30 | $353k | 27k | 13.06 |
| 2019-06-30 | $376k | 29k | 12.98 |
| 2019-03-31 | $387k | 24k | 16.39 |
| 2018-12-31 | $399k | 20k | 20.16 |
| 2018-09-30 | $430k | 17k | 24.85 |
| 2018-06-30 | $681k | 25k | 27.44 |
| 2018-03-31 | $791k | 26k | 30.94 |
| 2017-12-31 | $1.0M | 28k | 35.69 |
| 2017-09-30 | $671k | 24k | 27.52 |
| 2017-06-30 | $334k | 13k | 26.53 |
| 2017-03-31 | $0 | 13k | 0.00 |
| 2016-12-31 | $374k | 18k | 20.71 |
| 2016-09-30 | $370k | 23k | 16.17 |
| 2016-06-30 | $337k | 25k | 13.56 |
| 2016-03-31 | $686k | 39k | 17.45 |
| 2015-12-31 | $575k | 17k | 34.23 |
| 2015-09-30 | $434k | 15k | 29.99 |
| 2015-06-30 | $1.2M | 37k | 31.97 |
| 2015-03-31 | $529k | 26k | 20.76 |
| 2014-12-31 | $633k | 37k | 16.93 |
| 2014-09-30 | $358k | 19k | 19.35 |
| 2014-06-30 | $240k | 7.1k | 33.90 |